Shanghai Kaibao Pharmaceutical CO.,Ltd Company Description

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China.

Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight.

The company was founded in 2000 and is based in Shanghai, China.

Shanghai Kaibao Pharmaceutical CO.,Ltd

Country	China
Founded	2000
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,325
CEO	Yingbin Zhou

Contact Details

Address: No. 88 Chengpu Road Shanghai, 201401 China
Phone	86 21 3757 2030
Website	xykb.com

Stock Details

Ticker Symbol	300039
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100000JZ3
SIC Code	2834

Key Executives

Name	Position
Yingbin Zhou	GM and Director
Liwang Ren	Chief Financial Officer, Board Secretary and Non-Independent Director
Jianzhong Liu	Deputy GM and Non-Independent Director